Juvenile idiopathic arthritis

Area of Science:

• Rheumatology
• Pediatric Immunology
• Autoimmunity

Background:

• Juvenile idiopathic arthritis (JIA) presents diagnostic challenges due to variable clinical features and differing classification schemes.
• Limited objective serologic tests complicate JIA diagnosis and classification.
• Recent advances illuminate the immunology and immunopathology of JIA, paving the way for new treatments.

Purpose of the Study:

• To provide a comprehensive review of juvenile idiopathic arthritis (JIA).
• To emphasize clinical features, immunological characteristics, pathogenesis, and treatment options for JIA.
• To bridge genetic findings with clinical presentation and discuss quality of life, psychosocial, and socioeconomic outcomes.

Main Methods:

• Literature review focusing on historical basis, clinical features, immunology, pathogenesis, and treatment of JIA.
• Discussion of quality of life, psychosocial functioning, socioeconomic outcomes, and mortality in JIA.
• Integration of genetic observations with clinical presentation in the context of JIA.

Main Results:

• JIA classification remains challenging due to clinical heterogeneity and lack of objective markers.
• Significant progress has been made in understanding JIA's immunological underpinnings.
• Novel therapeutic strategies, including biologic agents, are emerging for JIA management.

Conclusions:

• A deeper understanding of JIA's clinical definition and its link to autoimmunity is crucial.
• Novel treatments, particularly biologic agents, offer improved patient care for JIA.
• Addressing psychosocial and socioeconomic aspects is vital for comprehensive JIA management.